BD Research Cloud 7.0 introduces Horizon Panel Maker to automate complex experiment setup
BD launches an AI-powered panel design tool for flow cytometry. Find out how it’s reshaping immunology and cancer research automation.
Ozelle’s 100B-image diagnostic AI platform puts scale and precision at the center of care
Ozelle’s AI-powered CBM platform debuts at WHX Dubai 2026. Discover how modular, guided diagnostics are transforming primary and veterinary care workflows.
Natera’s lung transplant biomarker study validates noninvasive dd-cfDNA surveillance model
Can a blood test replace lung biopsies? Natera’s Prospera test may reshape transplant care. Learn what the latest study means for diagnostics in organ health.
Can edge AI help redefine acute care? What GE HealthCare and NXP’s anesthesia and NICU concepts reveal
When GE HealthCare and NXP Semiconductors N.V. took the stage at CES 2026 to showcase their collaboration, it marked more than a moment of tech theater. The partnership unveiled two forward-looking concept technologies that aim to apply edge artificial intelligence to some of the most demanding environments in medicine: the operating room and the neonatal […]
Syracuse Orthopedic Specialists and three affiliates join Evolve Orthopedic Partners platform
Evolve Orthopedic Partners expands its musculoskeletal platform with four-practice deal in New York. Find out how this model could redefine MSO growth.
Can targeting neuropathy reverse tissue death? What the Rapid Nexus study means for chronic wound care
New study shows neuropathy reversal can restore healing in tissue facing amputation. Find out how Rapid Nexus could reshape wound care.
Why VitaSmart’s FDA nod could shift transplant strategies for extended-criteria grafts
Find out how Bridge to Life’s FDA-cleared VitaSmart system could reshape liver transplant workflows in 2026.
Could CereVasc’s eShunt replace VP shunts in post-aneurysmal hydrocephalus treatment?
CereVasc completes ETCHES trial enrollment for its eShunt device in post-SAH hydrocephalus. Learn what this means for future neurosurgical care.
Gore’s TIPS expansion device wins CE mark: Could 6–10 mm range reshape portal hypertension shunt strategies?
Gore’s VIATORR device earns CE mark for 6–10 mm range, enabling tailored TIPS procedures. Find out how this could reshape portal hypertension care.
Can Trisol’s TTVR platform solve the right heart puzzle in tricuspid regurgitation care?
Trisol’s valve shows early safety and efficacy in high-risk TR patients. Explore what this means for the future of transcatheter tricuspid therapies.